Protective efficacy of a two-in-one COVID-19/influenza vaccine from coinfection with SARS-CoV-2 and influenza virus

Research Project

Project/Area Number	24K23158
Research Category	Grant-in-Aid for Research Activity Start-up
Allocation Type	Multi-year Fund
Review Section	0605:Veterinary medical science, animal science, and related fields
Research Institution	Hokkaido University
Principal Investigator	ハンダビレチムカ北海道大学, ワクチン研究開発拠点, 博士研究員 (70994771)
Project Period (FY)	2024-07-31 – 2026-03-31
Project Status	Granted (Fiscal Year 2024)
Budget Amount *help	¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000) Fiscal Year 2025: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000) Fiscal Year 2024: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords	COVID-19 / Influenza / Coinfection / Vaccine / Protection
Outline of Research at the Start	Currently, SARS-CoV-2 and influenza virus are circulating at the same time. In this research, a coinfection mouse model will be established. Next, the two-in-one COVID-19/influenza whole virus particle vaccine will be prepared and its efficacy against coinfection will be investigated.